Accessibility Menu
IDenta logo

IDenta(OTC) IDTA

Current Price$0.22
Market Cap$890.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)-97%
5 Year-82%
1 Year-56%
1 Month+38%
IDenta last closing stock price
MetricPriceDate
Last closeUSD 0.222026-07-21
IDenta stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-17.54%USD 0.272026-07-13
1 month+37.5%USD 0.162026-06-17
3 month+25.71%USD 0.182026-04-21
Year to date+25.64%USD 0.182025-12-30
1 year-55.98%USD 0.502025-07-21
3 year-37.18%USD 0.352023-07-19
5 year-82.4%USD 1.252021-07-21
Since inception-97.11%USD 7.602003-06-16

IDenta Financials at a Glance

Market Cap

$890.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.69M

Net Income (TTM)

$190.49K

EPS (TTM)

$0.04

P/E Ratio

5.45

Dividend

$0.00

Beta (Volatility)

0.29 (Low)

Price

$0.22

Volume

25

Open

$0.22

Previous Close

$0.22

Daily Range

$0.22 - $0.22

52-Week Range

$0.15 - $0.49

Estimated Earnings Date

N/A

IDTA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About IDenta

IDenta Corp. operates as a detection and forensic science company, specializing in drug and explosives testing solutions. The company serves law enforcement, military, and government agencies globally, providing essential tools to combat illicit drugs and terrorist threats.

Products and Services
  • Drug testing kits for various substances
  • Explosives testing kits for security applications
  • Forensic products including urine and saliva drug testing
Growth Outlook
  • Recent quarterly revenue increased to $520,983, showing strong demand
  • Trailing twelve months (TTM) gross profit margin stands at 53.2%
  • Operating income ratio improved to 13.9%, indicating operational efficiency
Financial Highlights
  • Net income for Q1 2026 reached $29,860, reflecting profitability
  • Current ratio of 3.94 suggests strong liquidity position
  • Price-to-earnings (P/E) ratio of 4.67 indicates potential undervaluation
IDenta Corp. has established itself as a key player in the forensic science sector, with a diverse range of products that cater to critical needs in security and law enforcement. The company's recent financial performance indicates a positive trajectory, with significant revenue growth and improved profitability metrics. The strong liquidity position further enhances its ability to invest in future growth opportunities. With a low P/E ratio, the company may present an attractive option for investors looking for value in the healthcare sector.
AI Generated • Jul 24, 2026

Industry

Electronic Equipment, Instruments and Components

Sector

Information Technology

Employees

16

CEO

Amichai Glattstein

Website

www.identa-corp.com

Headquarters

Jerusalem, JM 93420, IL

IDTA Financials

Key Financial Metrics (TTM)

Gross Margin

53.20%

Operating Margin

21.22%

Net Income Margin

11.29%

Return on Equity

22.21%

Return on Capital

12.16%

Return on Assets

9.74%

Earnings Yield

18.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$890.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

4.05M

Volume

25

Avg. Volume

351.403

Financials (TTM)

Gross Profit

$897.64K

Operating Income

$357.97K

EBITDA

$284.49K

Operating Cash Flow

$87.45K

Capital Expenditure

-$17.10K

Free Cash Flow

$70.35K

Cash & ST Invst.

$310.69K

Total Debt

$633.47K

IDenta Performance Analysis

IDenta annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,338,754-3.8%
20232023-12-31USD 1,051,590-21.5%
20242024-12-31USD 1,455,48838.4%
20252025-12-31USD 1,341,040-7.9%
IDenta sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3095.5%
Q32025-09-3025.1%
Q42025-12-31-7.2%
Q12026-03-3131.3%
IDenta annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.03101.8%
20232023-12-31USD 0.00-91.0%
20242024-12-31USD 0.051667.7%
20252025-12-31USD 0.02-61.7%
IDenta sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30104.7%
Q32025-09-302314.3%
Q42025-12-31-1.8%
Q12026-03-31-55.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$520.98K

+198.0%

Gross Profit

$248.90K

+558.0%

Gross Margin

47.77%

N/A

Market Cap

$890.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$55.63K

N/A

Employees

16

N/A

Net Income

$29.86K

+148.5%

EBITDA

$101.23K

+286.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$310.69K

-10.5%

Total Debt

$633.47K

-8.6%

Accounts Receivable

$397.90K

+469.8%

Inventory

$474.26K

+18.3%

Long Term Debt

$534.07K

-1.5%

Short Term Debt

$99.40K

-34.0%

Return on Assets

9.74%

N/A

Return on Invested Capital

23.16%

N/A

Free Cash Flow

-$34.89K

+46.3%

Operating Cash Flow

-$32.25K

+48.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IVROInVitro International
$0.06-24.94%
CPMDCannaPharmaRX, Inc.
$0.00+0.00%
SZLSFStageZero Life Sciences Ltd.
$0.00+0.00%
ALIDAllied Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
NUNu Holdings
$14.09-0.01%

Questions About IDTA

What is the current price of IDenta?

IDenta is trading at $0.22 per share.

What is the 52-week range for IDenta?

Over the past 52 weeks, IDenta has traded between $0.15 and $0.49.

How much debt does IDenta have?

As of the most recent reporting period, IDenta reported total debt of $633.47K.

How much cash does IDenta have on hand?

IDenta reported $310.69K in cash and cash equivalents in its most recent financial results.

What is IDenta’s dividend yield?

IDenta does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services